Chart Industries, Inc. · NYSE:GTLS

Chart Industries — Investor Presentation (August 2016)

25 slides from Chart Industries's investor presentation, Aug 25, 2016

  1. Slide 1: Chart Industries, Inc. Investor Presentation August 2016

    © 2016 Chart Industries, Inc. Confidential and Proprietary Chart Industries, Inc. Investor Presentation August 2016 Exhibit 99.1

  2. Slide 2: Disclosure: Forward-Looking Statements

    © 2016 Chart Industries, Inc. Confidential and Proprietary 2 Disclosure Forward-Looking Statements: This presentation includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The use of words such as “may,” “might,” “should,” “will,” “expect,”

  3. Slide 3: Well Diversified Industry Leader

    © 2016 Chart Industries, Inc. Confidential and Proprietary 3 #1 or #2 in primary industries served Well Diversified Industry Leader $180M LTM as of 6/30/2016 Leading Industry Positions Robust Operating Cash Flows Significant Liquidity $450M Revolving Credit Facility

  4. Slide 4: Driven By Technology

    © 2016 Chart Industries, Inc. Confidential and Proprietary 4 Driven By Technology Chart is a recognized global brand for the design and manufacture of highly engineered cryogenic equipment used from beginning to end in the liquid gas supply chain. You may never use the products we make, but everyone

  5. Slide 5: Delivered Strong Growth Over Last Cycle

    © 2016 Chart Industries, Inc. Confidential and Proprietary 5 Delivered Strong Growth Over Last Cycle -17% +17% 2010-2014 CAGR LTM as of 6/30/2016 $0.95B FY 2015 $0.93B FY 2014 $1.15B FY 2010 $0.60B Orders $0.97B -19% +21% 2010-2014 CAGR LTM as of 6/30/2016 FY 2015 $1.04B FY 2014 $1.19B FY 2010 $0.56

  6. Slide 6: Unique Business Portfolio

    © 2016 Chart Industries, Inc. Confidential and Proprietary 6 Unique Business Portfolio Distribution & Storage (D&S) BioMedical Energy & Chemicals (E&C) Energy Industrial Healthcare Life Sciences In d u st rie s S e rv e d

  7. Slide 7: Strategically Located Operations

    © 2016 Chart Industries, Inc. Confidential and Proprietary 7 Corporate Energy & Chemicals Distribution & Storage BioMedical North America Strategically Located Operations Geographic diversification providing competitive advantage Europe Asia - Pacific

  8. Slide 8: Energy & Chemicals: Mission Critical Equipment Provider

    © 2016 Chart Industries, Inc. Confidential and Proprietary 8 Mission Critical Equipment Provider  Supplier of Brazed Aluminum Heat Exchangers (BAHX), Air Cooled Heat Exchangers (ACHX) and Cold Boxes  Provider of integrated systems and aftermarket services for gas processing, LNG and petrochemical

  9. Slide 9: Energy & Chemicals LTM Highlights

    © 2016 Chart Industries, Inc. Confidential and Proprietary 9 $115M Backlog at 6/30/16 55% 24% 13% 8% 4% 41% 55% Industry Serving Energy Markets Globally 26% of Total Chart Sales 32% Gross Margin Region LNG Industrial Gas Natural Gas Processing/ Petrochemical United States Asia ROW Energy & Chemicals

  10. Slide 10: Distribution & Storage: Leading Cryogenic Equipment Provider

    © 2016 Chart Industries, Inc. Confidential and Proprietary 10 Leading Cryogenic Equipment Provider Designer, manufacturer and service provider of cryogenic solutions for the storage and delivery of cryogenic liquids used in industrial gas and LNG applications  Complete portfolio of cryogenic distri

  11. Slide 11: Diversified Product Portfolio

    © 2016 Chart Industries, Inc. Confidential and Proprietary 11 Diversified Product Portfolio 52% of Total Chart Sales $253M Backlog at 6/30/16 55% 24% 9% 6% 6% 49% 21% 20% 10% D&S FY 2015 Sales of $487.6M 26% Gross Margin LNG Manufacturing/ Fabrication Asia Europe ROW United States Industry Region Fo

  12. Slide 12: BioMedical: Innovative Solution Provider

    © 2016 Chart Industries, Inc. Confidential and Proprietary 12 Innovative Solution Provider Healthcare, life science and environmental product lines built around our core competencies in cryogenics and gas processing, but with a focus on the users of cryogenic liquids and gases  End to end provider

  13. Slide 13: Serving Growing Global End Markets

    © 2016 Chart Industries, Inc. Confidential and Proprietary 13 Serving Growing Global End Markets 22% of Total Chart Sales 60% 29% 11% 41% 16% 32% 11% BioMed FY 2015 Sales of $221.6M $25M Backlog at 6/30/16 34% Gross Margin Asia Europe ROW United States Environmental Life Sciences Healthcare Industry

  14. Slide 14: Current Challenges and How We Are Addressing Them

    © 2016 Chart Industries, Inc. Confidential and Proprietary 14 Current Challenges  Compressed spread between gas and oil prices  Delayed investments in upstream equipment  Macroeconomic environment in China How we are addressing challenges  Aggressive cost reductions in down segments with headcou

  15. Slide 15: Dynamic Global Strategy

    © 2016 Chart Industries, Inc. Confidential and Proprietary 15 Dynamic Global Strategy Maximize LNG Opportunity  Expand Industrial Gas Offerings Innovation Through Technology Pursue New Growth Opportunities   

  16. Slide 16: Expand Industrial Gas Offerings

    © 2016 Chart Industries, Inc. Confidential and Proprietary 16 Expand Industrial Gas Offerings Global Strategy  Focus on high pressure heat exchangers  Best-in-Industry delivery  Expand long-term customer relationships through Lifecycle service offerings  Target developing areas where growth pote

  17. Slide 17: Maximize LNG Opportunity

    © 2016 Chart Industries, Inc. Confidential and Proprietary 17  Standardized small and midscale LNG plants  Expand our integrated system and aftermarket offerings  Capture floating liquefaction (FLNG) opportunities Maximize LNG Opportunity  Target R&D efforts on developing markets  Customer part

  18. Slide 18: Innovation Through Technology

    © 2016 Chart Industries, Inc. Confidential and Proprietary 18 Innovation Through Technology Eclipse 5® Portable Oxygen Concentrator Nomad™ Mobile Storage and Delivery System  New industrial products  Continued investment in LNG product offerings  Accelerated new product introduction  Improve por

  19. Slide 19: Pursue New Growth Opportunities

    © 2016 Chart Industries, Inc. Confidential and Proprietary 19 Pursue New Growth Opportunities Inorganic Vertical Integration Organic Technology Capability Capital Investments Research & Development Distribution Channels Global Strategy

  20. Slide 20: Strong Free Cash Flow Generation

    © 2016 Chart Industries, Inc. Confidential and Proprietary 20 Strong Free Cash Flow Generation Future Growth * Non-GAAP measure, see reconciliation to Operating Cash Flow in Appendix. Free cash flow equals operating cash flow minus capital expenditures. Q1 -20 -10 0 10 20 30 40 50 60 Q4 Q3 ($ millio

  21. Slide 21: Well Positioned For Continued Growth

    © 2016 Chart Industries, Inc. Confidential and Proprietary 21 $213M Cash at 6/30/2016 $450M Revolving Credit Facility Well Positioned For Continued Growth 2.59x Current Ratio* Significant Liquidity Solid Balance Sheet 25% Debt / Capital %** ** Total Debt (ST + LT Debt) / Total Capital (Common Equity

  22. Slide 22: Why Invest In Chart?

    © 2016 Chart Industries, Inc. Confidential and Proprietary 22 Why Invest In Chart?  Stable Industrial Gas business  Growing BioMedical opportunities  Long-term growth opportunities through build out of LNG  Selling to a wide range of global industries Well Diversified Business Proven Track Recor

  23. Slide 23: Appendix

    © 2016 Chart Industries, Inc. Confidential and Proprietary 23 Appendix

  24. Slide 24: Non-GAAP Reconciliation

    © 2016 Chart Industries, Inc. Confidential and Proprietary 24 2014 2015 2016 ($ millions) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Operating Cash Flow $20.9 $21.5 $23.8 $52.6 $0.9 $7.1 $46.4 $46.5 $38.2 $48.6 Capital Expenditures (10.4) (15.3) (17.2) (19.2) (14.8) (9.6) (11.6) (11.0) (5.2) (4.2) Free Cash Flow

  25. Slide 25: www.ChartIndustries.com

    © 2016 Chart Industries, Inc. Confidential and Proprietary www.ChartIndustries.com 25

Chart Industries — Investor Presentation (August 2016) on 6ix